Episode 2: NMO Treatments: Acute vs Maintenance - a podcast by The Sumaira Foundation and Connor B Judge Foundation
from 2019-10-24T10:20
Episode 2 of Demystifying NMO by The Sumaira Foundation (TSF) for NMO and Connor B Judge Foundation (CBFJ) focuses on NMO Treatments: Acute vs Maintenance. Follow along to hear a candid conversation between Connor, of the CBJF and NMO patient, and his sister Chelsey, also scientific advisor with the CBJF. In their discussion, they talk about the differences in treatments to manage an active relapse versus to help prevent relapse.
Glossary of Terms Used
AQP4: aquaporin-4; a water channel protein found in the CNS; antibodies can be made against this in NMOSD patients
B-cell: a white blood cell that is a key component of the adaptive immune system and makes antibodies
Immunosuppressant: a medication that reduces/supresses the function of some immune system component
MOG: myelin-oligodendrocyte glycoprotein; a myelin protein; antibodies can be made against this in some NMOSD patients
Relapse: clinical disease activity/clinical worsening
Further episodes of Demystifying NMO & MOG
Further podcasts by The Sumaira Foundation and Connor B Judge Foundation
Website of The Sumaira Foundation and Connor B Judge Foundation